These data revealed the in vitro and in vivo relevance for the direct UBA52-dependent regulation of α-synuclein via interaction, along with the strong implication of UBA52 in regulating the PD-specific pathological markers and protein aggregation tendency during the acute phase of disease pathogenesis. The gene discussed is SNCA; the disease is Parkinson disease.